- ASSOCIATE PROFESSOR | Medicine, Endocrinology, Diabetes and Bone Disease
- ASSOCIATE PROFESSOR | Obstetrics, Gynecology and Reproductive Science
- Endocrine, Diabetes and Bone Diseases
- Hospital Affiliation
- The Mount Sinai Hospital
- The Mount Sinai Diabetes Center 212-241-3422212-241-3422
Carol J. Levy, MD, CDE is an Associate Professor in the Department of Medicine, Division of Endocrinology, Diabetes and Bone Disease, and an Associate Professor in the Department of Obstetrics, Gynecology and Reproductive Science. She is a board-certified Endocrinologist and Certified Diabetes Educator.
Dr. Levy is the Director of the Mount Sinai Diabetes Center and Type 1 Diabetes Clinical Research. She is an expert in type 1 diabetes and diabetes in pregnancy as well as general endocrinology. She has over 20 years experience managing patients with these conditions.
Dr. Levy attended medical school with the goal of becoming a physician that she would want to see as a patient. Dr. Levy believes that Endocrinology is an area where physicians help guide patients on the right path to improve health but the “ball” is really in the patient’s court. For Dr. Levy, the role of the physician to educate and support the patient is of key importance. During her training at Joslin Clinic, she developed an interest in taking care of pregnant women with diabetes and delighted in the challenge of caring for “2” patients. She finds general endocrinology both exciting and fascinating as well. Explaining the reason the thyroid works the way it does, hormonal fluctuations and the impact of this on an individual, and the reasons at times the pancreas (the gland that normally makes insulin) does not, is critical to help people take care of their illnesses. As a child, she was diagnosed with type 1 diabetes and the patience and respect she received from clinicians along the way (including her obstetrician for her own pregnancies) reinforced her belief that a patient who understands the purpose of a treatment is one who is able to best able to manage his//her disease. Returning calls and answering questions thoroughly is a priority. She strives to see patients at their scheduled time so arriving for appointments 5-10 minutes early is greatly appreciated by all patients on her schedule.
As the Director of the Artificial Pancreas Research Program, she and her team strives to continue to improve the lives and glucose control of people with diabetes, by forwarding this technology through both research and clinical care. This pioneering clinical research program collaborates with multiple researchers both nationally and internationally and has the potential to revolutionize the management of patients with type 1 diabetes.
- Gestational Diabetes
- Polycystic Ovary Syndrome
- Type 1 Diabetes
- Type 2 Diabetes
MD, Northwestern Univ Medical School
Residency, Internal Medicine
Beth Israel Deaconess Medical Center- Harvard Medical School
Beth Israel Deaconess Medical Center- Harvard Medical School
My academic interests are in the area of clinical trials for development of new treatments for medical conditions within the department of medicine. I coordinate the staff of the clinical trials office and the regulatory and research coordinators who work in this office. Our goals are to assist investigators to have smooth and prompt development of research protocols as well as provide the support to perform these clinical trials and select trials which will hopefully provide benefit to patients along the whole spectrum of disease states.
Alkon C. Balancing Pregnancy with Pre-existing Diabetes [review]. Healthy Mom, Healthy, Baby 2010;.
Mechanic J, BRETT E. Diabetes in Pregnancy. Power of Nutrition Handbook 2009;.
LEVY C, DAVIES T. Diabetes in Pregnancy. A Case Based Guide to Clinical Endocrinology 2008;.
Baron-Faust R, Buyon J. The Autoimmune Connection: Essential Information for Women on Diagnosis, Treatment, and Getting on with Your Life [editorial]. 2004;.
Laliberte R. Stopping Diabetes in Its Tracks: The Definitive Take-Charge Guide [review]. Reader’s Digest Association, Inc., 2002;.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr.Levy did not report having any of the following types of financial relationships with industry during 2016 and/or 2017: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.